Perfusion

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFarlane, T.
Right arrow Articles by Kleinloog, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by McFarlane, T.
Right arrow Articles by Kleinloog, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perfusion, Vol. 22, No. 2, 103-113 (2007)
DOI: 10.1177/0267659107078014

Does cold blood cardioplegia solution cause deterioration in clinical pulmonary function following coronary artery bypass graft surgery?

Tamra McFarlane

Dept. Surgery, Nelson Mandela School of Medicine, University of Kwa-Zulu Natal, South Africa, tamra{at}dbn.stormnet.co.za

Robert Kleinloog

Dept. Cardiothoracic Surgery, Inkosi Albert Luthuli Hospital, University of Kwa-Zulu Natal, South Africa

Objective: Deterioration in pulmonary function is a common complication following coronary artery bypass graft surgery and there is still speculation to the precise causative factors thereof. Cardioplegia solution not drained by the atriocaval cannula enters the lung parenchyma unless removed by a pulmonary artery (PA) vent. The hypothesis of the present study was that cold blood cardioplegia solution damages the lung parenchyma, resulting in an observed deterioration of clinical lung function.

Methods: A prospective, double-blind, randomised trial was conducted on 142 patients. The study group of 71 patients had a PA vent inserted at the time of cannulation, preventing cardioplegia from going through the lungs. In addition, positive end expiratory pressure (PEEP) was applied and low-volume lung ventilation carried out during cardiopulmonary bypass (CPB). The control group (n = 71) had cardioplegia enter the lung parenchyma during cardiopulmonary bypass. Clinical parameters of arterial blood gases, including estimated shunt fraction, spirometry tests and radiographic analysis was made preoperatively and at set times through the postoperative period.

Results: Baseline demographics and intraoperative and postoperative management was the same in both groups, thus, yielding a homogenous sample for analysis. Significant changes were noted in arterial blood gases, spirometry, and radiographic analysis of effusion and atelectasis over the time periods studied (p < 0.001). There was, however, no significant difference between the study and control groups at any point (p > 0.05). Conclusions: The data, therefore, suggest that allowing cold blood cardioplegia solution to circulate the lungs during cardiopulmonary bypass does not have any (beneficial or detrimental) effect on clinical lung function postoperatively. Perfusion (2007) 22, 103—113.

Key Words: cardiac surgery • clinical pulmonary function • cold blood cardioplegia • pulmonary artery vent


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?